Risk of an immature electronic medical records market and delayed adoption
First written in FY2016. 14 of 16 entries say "Restated". Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025RestatedAnnual report
「Our group is investing in the development, sale and other activities necessary to establish a business involving electronic medical records, which are infrastructure for healthcare IT. However, if our strategy fails to respond to changes in the environment surrounding electronic medical records and the investment does not generate the expected returns, our group's operating results and financial condition could be affected.」
The risk of failing to respond to changes in the environment surrounding electronic medical records and insufficient recovery of investment is reconfirmed. - FY2023-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」
It states that there have been no material changes in the risk of an immature electronic medical records market and delayed adoption described in the previous fiscal year. - FY2022-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」
It states that there have been no material changes in the risk of an immature electronic medical records market and delayed adoption described in the previous fiscal year. - FY2020-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」
It states that there have been no material changes in the risk of an immature electronic medical records market and delayed adoption described in the previous fiscal year. - FY2019SoftenedAnnual report
「Our group is investing in the development, sale and other activities necessary to establish a business involving electronic medical records, which are infrastructure for healthcare IT. However, if adoption of electronic medical records is delayed, our strategy fails to produce results and the investment does not generate the expected returns, our group's operating results and financial condition could be affected.」
Although the previous wording that "the market remains immature" has been removed, the possibility of delayed adoption of electronic medical records and insufficient recovery of investment continues to be disclosed. - FY2019-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」
It states that there have been no material changes in the risk of an immature electronic medical records market and delayed adoption described in the previous fiscal year. - FY2019-Q2RestatedAnnual report
「During the cumulative second quarter of the current fiscal year, there were no material changes in the financial position, operating results or cash flow, including any abnormal fluctuations, or in the “Business and Other Risks” described in the annual securities report for the previous fiscal year. There are also no material events or similar matters.」
It states that there have been no material changes in the risk of an immature electronic medical records market and delayed adoption described in the previous fiscal year. - FY2019-Q1RestatedAnnual report
「During the cumulative first quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」
No material changes are considered to have occurred in the risk of an immature electronic medical records market and delayed adoption described in the previous fiscal year. - FY2018-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」
Explicitly states that there have been no material changes to the business and other risks described in the previous fiscal year. - FY2018-Q2RestatedAnnual report
「During the cumulative second quarter of the current fiscal year, there were no material changes in the financial position, operating results or cash flow, including any abnormal fluctuations, or in the “Business and Other Risks” described in the annual securities report for the previous fiscal year. There are also no material events or similar matters.」
No material changes are considered to have occurred in the risk of an immature electronic medical records market and delayed adoption described in the previous fiscal year. - FY2018-Q1RestatedAnnual report
「During the cumulative first quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」
Explicitly states that there have been no material changes to the business and other risks described in the previous fiscal year. - FY2017RestatedAnnual report
「Our group is investing in the development, sale and other activities necessary to establish a business involving electronic medical records, which are infrastructure for healthcare IT. However, as the market remains immature, if adoption of electronic medical records is delayed, our strategy fails to produce results and the investment does not generate the expected returns, our group's operating results and financial condition could be affected.」
The shortfall in investment recovery resulting from an immature electronic medical records market and delayed adoption continues to be identified as a business-strategy risk. - FY2017-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」
No material changes are considered to have occurred in the risk of an immature electronic medical records market and delayed adoption. - FY2017-Q2RestatedAnnual report
「During the cumulative second quarter of the current fiscal year, there were no material changes in the financial position, operating results or cash flow, including any abnormal fluctuations, or in the “Business and Other Risks” described in the annual securities report for the previous fiscal year. There are also no material events or similar matters.」
No material changes are considered to have occurred in the risk of an immature electronic medical records market and delayed adoption. - FY2017-Q1RestatedAnnual report
「During the cumulative consolidated period of the first quarter, there were no material changes in unusual fluctuations, etc., in financial position, operating results or cash flows, or in the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
Explicitly states that there have been no material changes to the business and other risks described in the previous fiscal year. - FY2016First statedAnnual report
「Our group is investing in the development, sale and other activities necessary to establish a business involving electronic medical records, which are infrastructure for healthcare IT. However, as the market remains immature, if adoption of electronic medical records is delayed, our strategy fails to produce results and the investment does not generate the expected returns, our group's operating results and financial condition could be affected.」
The risk identified is insufficient recovery of investment in the electronic medical records business due to an immature market and delayed adoption.